One innovative approach for HSP70 delivery involves cell-penetrating peptides (CPPs), such as PepFect14 [231], which efficiently transfect HSP70 into cells, offering therapeutic potential for diseases like Parkinson's and Alzheimer's. This evidence concerns the gene HSPA1A and Parkinsonism.